Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.
Mandell
Lionel A
LA
McMaster University, Hamilton, Ontario, Canada. lmandell@mcmaster.ca
Bartlett
John G
JG
Dowell
Scott F
SF
File
Thomas M
TM
Musher
Daniel M
DM
Whitney
Cynthia
C
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000032:analysis; D023482:Bioterrorism; D002439:Cefotaxime / Q000494:pharmacology; D002443:Ceftriaxone / Q000494:pharmacology; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification; D017714:Community-Acquired Infections / Q000188:drug therapy*; D006801:Humans; D007877:Legionnaires' Disease / Q000188:drug therapy; D018942:Macrolides / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D011014:Pneumonia / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D018942:Macrolides; D002443:Ceftriaxone; D002439:Cefotaxime